Sanofi India rallies after HC ruling on Shantha-tax case
By IRIS
15th February 2013 05:18 PM
Sanofi India, the leading pharmaceutical
companies of the world, surged on Friday after the Andhra Pradesh
high court ruled that French drug multinational Sanofi Aventis will
not have to pay taxes in India for a deal with Hyderabad-based
vaccine firm Shantha Biotechnics.
Shares ofthe companysettled at Rs
2,306, up Rs 85.1, or 3.83% at the Bombay Stock Exchange (BSE) on
Friday. In the earlier session, the shares lost 1.81%, or Rs 40.9,
at Rs 2,220.90. The scrip has touched an intra-day high of Rs 2,400
and low of Rs 2,180. The total volume of shares traded at the BSE
is 2,896.Currently, the stock is trading down 5.88% from its
52-week high of Rs 2,450 and above 15.18% over the 52-week low of
Rs 2,002.10.
Recent Activity
- India's bleeding insurgencies: Lessons from Latin America
- Lot more to India-China ties than border stand-off: Experts
- Major industrial conglomerates making a beeline for Haryana
- Man kidnapped 23 years ago finds kin thanks to Google Maps
- Bangalore's techies start 'brand tattoos' craze
- Indian circuses struggle to adapt after court bans
- Want hassle-free tatkal ticket? Personally visit special counters
- Tamil Brahmi script dating to 500 BC found near Erode
- Rs 8K-crore plan for upgrading ICVs of Army
- Man arrested for attempt to attack TV host Ranjini Haridas
- Kalabhavan Mani missing after assaulting forest staff
- Tamil Brahmi script dating to 500 BC found near Erode
- Sreesanth, 2 other players 'confess'; more players under scanner
- 'Sreesanth confesses to spot-fixing charge'
- Meghalaya's CMJ University faces probe after awarding suspicious PhDs
- Want hassle-free tatkal ticket? Personally visit special counters
Post a Comment